While many people were surprised at Donald Trump’s victory over Hillary Clinton in the U.S. Presidential race, the impact was substantial in terms of pharmaceutical stocks, which reportedly surged in Europe on Wednesday. According to Fortune, Trump’s victory led investors to believe the threat of tough action against pricing of pharmaceutical drugs had subsided. News reports indicate that, following the …
Pharma Marking – First Marijuana-Based Therapy Approved In U.S.?
Recently it was announced that Epidiolex, a marijuana-based therapy that received impressive clinical trial results for experimental therapy in those with LGS (Lenox-Gastaut Syndrome), could be the first marijuana-based drug in the U.S. if GW Pharmaceuticals wins regulatory clearance. Trial results sent GW’s stock soaring with shares closing at $126.06. The pharmaceutical company’s results help set the stage for application …
Pharma Traceability – U.S. Rights For Toprol-XL Sold
Recently it was announced that AstraZeneca PLC, a UK-based biopharmaceutical firm, would sell the U.S. rights to Toprol-XL, a generic drug for hypertension, to Aralez Pharmaceuticals Trading DAC, a unit of global specialty pharmaceutical company, Aralez Pharmaceuticals Inc. Toprol-XL was initially approved as a medicine used to control high blood pressure, heart failure, and angina in the United States nearly …
Plastic Packaging Waste – Dow Chemical Litter/Debris Solutions
Dow Chemical Company recently announced at the inaugural Our Ocean Conference in Washington, DC that the company will spend $2.8 million in an effort to find solutions to the problem of plastic packaging waste impacting our marine wildlife and oceans around the world. The conference was hosted by U.S. Secretary of State John Kerry. Dow recognizes that oceans and waterways …
Pharma Marking: Walgreens Aims To Make Healthcare More Affordable
Recently it was announced that Walgreens and Blue Cross-owned PBM Prime Therapeutics would partner in a combined specialty and mail services company aimed at assisting health plan enrollees in adhering to medications, making healthcare more affordable, and more. Prime Therapeutics is owned by more than a dozen Blue Cross and Blue Shield health plans, and is a large pharmacy benefit …